Freenome, Siemens Join Forces to Develop Blood Test for Breast Cancer
The humble mammogram may soon be getting a complementary new partner to boost breast cancer screening, Fierce Biotech reports.
The humble mammogram may soon be getting a complementary new partner to boost breast cancer screening, Fierce Biotech reports.
BTL’s Emsculpt Neo has received FDA clearance to stimulate neuromuscular tissue in the legs and arms for rehabilitation, expanding its original use for fat reduction and muscle building to now address medical conditions and improve patients’ mobility and recovery.